NCT06900933

Brief Summary

Is the use of collagen membrane on top of particulate bone mixture covered by onlay bone block in Maxilla better than the use of mixture of particulate bone covered by onlay bone block without the use of collagen membrane, in terms of bone quantity?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 28, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

May 28, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2026

Completed
Last Updated

July 16, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

March 21, 2025

Last Update Submit

July 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quantity of bone gain.

    Measured using linear measurements from Cone Beam Computed Tomography in millimeters.

    At 5 months from ridge augmentation.

Secondary Outcomes (1)

  • Soft Tissue Dehiscence

    Baseline 1st Week. Written Binary Numerical Yes or No.

Study Arms (2)

Study Group A: Retromolar bone block covered with collagen membrane.

EXPERIMENTAL

The onlay bone block harvested from retromolar region and fixed with micro screws, a mixture of autogenous and xenogenic particulate bone graft is going to be packed in between the bone block and recipient site. The assembly is going to be covered with native collagen membrane and fixed with titanium bone tacks.

Procedure: Onlay bone block covered with collagen membrane

Control Group B: Retromolar bone block without collagen membrane.

ACTIVE COMPARATOR

The onlay bone block harvested from retromolar region and fixed with micro screws, a mixture of autogenous and xenogenic particulate bone graft is going to be packed in between the bone block and recipient site.

Procedure: Onlay bone block without collagen membrane

Interventions

Onlay bone block covered with collagen membrane

Study Group A: Retromolar bone block covered with collagen membrane.

Onlay bone block covered without collagen membrane

Control Group B: Retromolar bone block without collagen membrane.

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with maxillary residual alveolar bone height not less than 8 mm.
  • Alveolar bone width from less than or equal 5 mm.
  • Both genders.
  • At least missing single tooth.
  • Previous Failed Implants.
  • Previous Failed Grafting.

You may not qualify if:

  • Heavy smokers more than 20 cigarettes per day.
  • Patients with alcohol abuse
  • Patients with narcotic abuse.
  • Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
  • Patients had radiotherapy and chemotherapy in head and neck.
  • Patients had neoplasms in sites to be grafted.
  • Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.
  • Pregnant females.
  • Patients with Para functional habits, apprehensive and non-cooperative.
  • Bone pathology related to the site to be grafted.
  • Psychological problems, stress situation (socially or professionally), emotional instability, and unrealistic patients' expectations.
  • Intraoral soft and hard tissue pathology.
  • Systemic condition that contraindicate implant placement.
  • Under the age of 18 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry Cairo University

Cairo, 11553, Egypt

RECRUITING

Related Publications (8)

  • Hammerle CH, Jung RE. Bone augmentation by means of barrier membranes. Periodontol 2000. 2003;33:36-53. doi: 10.1046/j.0906-6713.2003.03304.x. No abstract available.

    PMID: 12950840BACKGROUND
  • Cash and Alex: 20 years of guided bone regeneration in implant dentistry, 2nd ed. (2009).

    BACKGROUND
  • Urban, I A., Nagrusky H, Lozada JM:

    BACKGROUND
  • Urban, I A., Nagrusky H, Lozada JM.:

    BACKGROUND
  • Pellegrino G, Lizio G, Corinaldesi G, Marchetti C. Titanium Mesh Technique in Rehabilitation of Totally Edentulous Atrophic Maxillae: A Retrospective Case Series. J Periodontol. 2016 May;87(5):519-28. doi: 10.1902/jop.2016.150432. Epub 2016 Jan 12.

    PMID: 26759078BACKGROUND
  • Polis-Yanes C, Cadenas-Sebastian C, Gual-Vaques P, Ayuso-Montero R, Mari-Roig A, Lopez-Lopez J. Guided Bone Regeneration of an Atrophic Maxilla Using Heterologous Cortical Lamina. Case Rep Dent. 2019 Jun 11;2019:5216362. doi: 10.1155/2019/5216362. eCollection 2019.

    PMID: 31308978BACKGROUND
  • Jensen J, Sindet-Pedersen S. Autogenous mandibular bone grafts and osseointegrated implants for reconstruction of the severely atrophied maxilla: a preliminary report. J Oral Maxillofac Surg. 1991 Dec;49(12):1277-87. doi: 10.1016/0278-2391(91)90303-4.

    PMID: 1955919BACKGROUND
  • Montazem A, Valauri DV, St-Hilaire H, Buchbinder D. The mandibular symphysis as a donor site in maxillofacial bone grafting: a quantitative anatomic study. J Oral Maxillofac Surg. 2000 Dec;58(12):1368-71. doi: 10.1053/joms.2000.18268.

    PMID: 11117684BACKGROUND

Central Study Contacts

Mohannad A. Ismail, MSc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

March 21, 2025

First Posted

March 28, 2025

Study Start

May 28, 2025

Primary Completion

November 15, 2025

Study Completion

February 15, 2026

Last Updated

July 16, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations